P Maurel

3.8k total citations · 1 hit paper
17 papers, 3.1k citations indexed

About

P Maurel is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, P Maurel has authored 17 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in P Maurel's work include Pharmacogenetics and Drug Metabolism (8 papers), Glycosylation and Glycoproteins Research (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). P Maurel is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Glycosylation and Glycoproteins Research (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). P Maurel collaborates with scholars based in France, United States and Mali. P Maurel's co-authors include R. U. Margolis, Uwe Rauch, Steven Wrighton, Jiong Zhang, Kazuto Yasuda, Mark S. Boguski, Ann K. Daly, Stephen C. Strom, Cynthia Brimer and Peter Kuehl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

P Maurel

17 papers receiving 3.0k citations

Hit Papers

Sequence diversity in CYP3A promoters and characterizatio... 2001 2026 2009 2017 2001 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Maurel France 12 1.7k 1.1k 914 631 454 17 3.1k
Mahfoud Assem United States 22 1.5k 0.9× 1.4k 1.2× 851 0.9× 722 1.1× 80 0.2× 33 3.2k
Sevasti B. Koukouritaki United States 20 605 0.4× 393 0.3× 542 0.6× 385 0.6× 148 0.3× 28 1.8k
Éric Lévesque Canada 32 1.3k 0.7× 721 0.6× 1.4k 1.6× 478 0.8× 52 0.1× 101 3.1k
Maria Thomas Germany 26 342 0.2× 422 0.4× 823 0.9× 90 0.1× 91 0.2× 62 2.1k
S S Thorgeirsson United States 26 1.1k 0.7× 881 0.8× 1.7k 1.9× 205 0.3× 160 0.4× 43 4.1k
Mayumi Saeki Japan 23 483 0.3× 722 0.6× 730 0.8× 413 0.7× 14 0.0× 58 1.7k
J�rgen Lehmann Germany 10 953 0.6× 774 0.7× 761 0.8× 141 0.2× 91 0.2× 16 2.0k
Patrick Caron Canada 30 595 0.4× 770 0.7× 778 0.9× 312 0.5× 23 0.1× 80 2.4k
Ryan Owen United States 17 293 0.2× 535 0.5× 719 0.8× 280 0.4× 14 0.0× 35 2.4k
Isabelle Dussault United States 23 684 0.4× 1.4k 1.2× 1.0k 1.1× 193 0.3× 53 0.1× 65 2.8k

Countries citing papers authored by P Maurel

Since Specialization
Citations

This map shows the geographic impact of P Maurel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Maurel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Maurel more than expected).

Fields of papers citing papers by P Maurel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Maurel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Maurel. The network helps show where P Maurel may publish in the future.

Co-authorship network of co-authors of P Maurel

This figure shows the co-authorship network connecting the top 25 collaborators of P Maurel. A scholar is included among the top collaborators of P Maurel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Maurel. P Maurel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dvořák, Zdeněk, P Maurel, M.J. Vilarem, Jitka Ulrichová, & Martin Modrianský. (2006). Expression and transcriptional activities of nuclear receptors involved in regulation of drug-metabolizing enzymes are not altered by colchiceine: Focus on PXR, CAR, and GR in primary human hepatocytes. Cell Biology and Toxicology. 23(2). 141–141. 1 indexed citations
2.
Kuehl, Peter, Jiong Zhang, Jatinder K. Lamba, et al.. (2001). Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nature Genetics. 27(4). 383–391. 1753 indexed citations breakdown →
3.
Drocourt, Lionel, Jean‐Marc Pascussi, Eric Assénat, et al.. (2001). Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes.. PubMed. 29(10). 1325–31. 92 indexed citations
4.
Gerbal‐Chaloin, Sabine, Jean‐Marc Pascussi, Lydiane Pichard‐Garcia, et al.. (2001). Induction of CYP2C genes in human hepatocytes in primary culture.. PubMed. 29(3). 242–51. 260 indexed citations
5.
Pichard‐Garcia, Lydiane, et al.. (2000). Human Hepatocytes in Primary Culture Predict Lack of Cytochrome P-450 3A4 Induction by Eletriptan In Vivo. Drug Metabolism and Disposition. 28(1). 51–57. 39 indexed citations
6.
Calleja, Cécile, Jean‐Marc Pascussi, J. C. Mani, P Maurel, & M.J. Vilarem. (1998). The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nature Medicine. 4(1). 92–96. 85 indexed citations
7.
Calleja, Cécile, Jean‐Marc Pascussi, J. C. Mani, P Maurel, & M.J. Vilarem. (1998). Reply to Rifampicin: a glucocorticoid receptor ligand?. Nature Medicine. 4(10). 1090–1091. 4 indexed citations
8.
Jounaïdi, Youssef, et al.. (1997). Role of the liver-enriched transcription factors C/EBPα and DBP in the expression of human CYP3A4 and CYP3A7. Journal of Hepatology. 26. 54–62. 38 indexed citations
9.
Chang, Thomas K. H., Yu Li, P Maurel, & David J. Waxman. (1997). Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines.. PubMed. 57(10). 1946–54. 167 indexed citations
10.
Pichard, Lydiane, et al.. (1996). The Fetal Specific GeneCYP3A7Is Inducible by Rifampicin in Adult Human Hepatocytes in Primary Culture. Biochemical and Biophysical Research Communications. 225(2). 689–694. 53 indexed citations
12.
Karthikeyan, Laina, et al.. (1992). Cloning of a major heparan sulfate proteoglycan from brain and identification as the rat form of glypican. Biochemical and Biophysical Research Communications. 188(1). 395–401. 46 indexed citations
13.
Rauch, Uwe, Laina Karthikeyan, P Maurel, R. U. Margolis, & Renée K. Margolis. (1992). Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain.. Journal of Biological Chemistry. 267(27). 19536–19547. 284 indexed citations
14.
McManus, Michael E., et al.. (1992). Cytochrome P-450 3A4 (nifedipine oxidase) is responsible for the C-oxidative metabolism of 1-nitropyrene in human liver microsomal samples.. PubMed. 52(22). 6237–43. 21 indexed citations
15.
Maurel, P, et al.. (1991). Removal of N-linked oligosaccharides of presumptive ectoderm impairs neural induction in Pleurodeles waltl. Mechanisms of Development. 33(3). 201–213. 1 indexed citations
16.
Blanc, Pierre, Hervé Etienne, Isabelle Fabre, et al.. (1991). Antiproliferative effect of FK 506 and cyclosporine on adult human hepatocytes in culture.. PubMed. 23(6). 2821–4. 6 indexed citations
17.
Larroque, Christian, Reinhard Lange, P Maurel, Réjean Langlois, & Johan E. van Lier. (1989). Rat liver microsomal progesterone metabolism: Evidence for differential Troleandomycin and pregnenolone 16α-carbonitrile inductive effects in the cytochrome P-450 III family. Journal of Steroid Biochemistry. 33(2). 277–286. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026